| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 8-K | Report | Data | 8-K | Sep 13, 2024 | Sep 9, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 13, 2024 | Aug 13, 2024 |
| SC 13G/A | Report | May 21, 2024 | ||
| 8-K | Report | Data | 8-K | May 13, 2024 | May 10, 2024 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMA -- SCHEDULE 13D/A(#1) | May 8, 2024 | |
| 10-Q | Report | Data | 10-Q | May 7, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 7, 2024 | May 7, 2024 |
| 10-K/A | Report | Data | 10-K/A | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Report | Data | 10-K | Mar 28, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Mar 28, 2024 | Mar 28, 2024 |
| 8-K | Report | Data | 8-K | Feb 23, 2024 | Feb 20, 2024 |
| SC 13G | Report | Feb 5, 2024 | ||
| SC 13G | Report | Jan 17, 2024 | ||
| SC 13D | Report | Dec 26, 2023 | ||
| SC 13D/A | Report | SC 13D/A | Dec 15, 2023 | |
| 8-K | Report | Data | 8-K | Dec 14, 2023 | Dec 14, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 13, 2023 | Nov 13, 2023 |
| 8-K | Report | Data | 8-K | Oct 30, 2023 | Oct 30, 2023 |
| 8-K | Report | Data | 8-K | Oct 10, 2023 | Oct 9, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 10, 2023 | Aug 10, 2023 |
| 8-K | Report | Data | 8-K | Jun 7, 2023 | Jun 6, 2023 |
| SC 13D/A | Report | SC 13D/A | May 30, 2023 | |
| SC 13D/A | Report | SC 13D/A | May 15, 2023 | |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 11, 2023 | May 11, 2023 |
| SC 13D/A | Report | SC 13D/A | May 9, 2023 | |
| 8-K | Report | Data | 8-K | May 5, 2023 | May 5, 2023 |
| 8-K | Report | Data | 8-K | May 3, 2023 | May 3, 2023 |
| 10-K | Report | Data | 10-K | Mar 27, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 27, 2023 | Mar 27, 2023 |
| 8-K | Report | Data | 8-K | Mar 14, 2023 | Mar 14, 2023 |
| 8-K | Report | Data | 8-K | Mar 10, 2023 | Mar 10, 2023 |
| 8-K | Report | Data | 8-K | Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 8, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 8, 2022 | Nov 8, 2022 |
| SC 13D/A | Report | SC 13D/A | Sep 30, 2022 | |
| SC 13D/A | Report | SC 13D/A | Aug 11, 2022 | |
| 10-Q | Report | Data | 10-Q | Aug 9, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 9, 2022 | Aug 9, 2022 |
| 8-K | Report | Data | 8-K | Aug 2, 2022 | Aug 2, 2022 |
| 8-K | Report | Data | 8-K | Jun 2, 2022 | Jun 1, 2022 |
| 10-Q | Report | Data | 10-Q | May 10, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 10, 2022 | May 10, 2022 |
| 10-K | Report | Data | 10-K | Mar 23, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 23, 2022 | Mar 23, 2022 |
| 8-K | Report | Data | 8-K | Mar 7, 2022 | Mar 2, 2022 |
| 8-K | Report | Data | 8-K | Feb 2, 2022 | Feb 2, 2022 |
| SC 13D/A | Report | SC 13D/A | Jan 27, 2022 | |
| SC 13G | Report | SC 13G | Jan 26, 2022 | |
| 8-K | Report | Data | 8-K | Jan 24, 2022 | Jan 18, 2022 |
| 8-K | Report | Data | 8-K | Dec 27, 2021 | Dec 23, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 12, 2021 | Nov 11, 2021 |
| 8-K | Report | Data | 8-K | Oct 12, 2021 | Oct 11, 2021 |
| 8-K | Report | Data | 8-K | Aug 11, 2021 | Aug 11, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2021 | Jun 30, 2021 |
| 8-K | Report | Data | 8-K | Aug 11, 2021 | Aug 11, 2021 |
| 10-Q | Report | Data | 10-Q | May 20, 2021 | Mar 31, 2021 |
| 8-K | Report | Data | 8-K | May 20, 2021 | May 20, 2021 |
| 8-K | Report | 8-K | May 14, 2021 | May 11, 2021 |
| SC 13D | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D | Apr 23, 2021 | |
| SC 13D | Report | SC 13D | Apr 20, 2021 | |
| SC 13D | Report | SC 13D | Apr 19, 2021 | |
| SC 13D | Report | SC 13D | Apr 14, 2021 | |
| 8-K | Report | 8-K | Apr 13, 2021 | Apr 13, 2021 |